Global Blood Therapeutics CEO Ted Love's 2020 pay jumps 74% to $18M
Global Blood Therapeutics reports 2020 executive compensation
By ExecPay News
Published: April 28, 2021
Global Blood Therapeutics reported fiscal year 2020 executive compensation information on April 28, 2021.
In 2020, five executives at Global Blood Therapeutics received on average a compensation package of $8.4M, a 84% increase compared to previous year.
Average pay of disclosed executives at Global Blood Therapeutics
Ted W. Love, Chief Executive Officer, received $18M in total, which increased by 74% compared to 2019. 67% of Love's compensation, or $12M, was in stock awards. Love also received $467K in non-equity incentive plan, $4.7M in option awards, $661K in salary, as well as $5K in other compensation.
For fiscal year 2020, the median employee pay was $373,366 at Global Blood Therapeutics. Therefore, the ratio of Ted W. Love's pay to the median employee pay was 47 to one.
David Johnson, Chief Commercial Officer, received a compensation package of $6.3M, which increased by 98% compared to previous year. 64% of the compensation package, or $4M, was in stock awards.
Jeffrey Farrow, Chief Financial Officer, earned $6M in 2020, a 89% increase compared to previous year.
Jung Choi, Chief Business and Strategy Officer, received $5.9M in 2020, which increases by 90% compared to 2019.
Tricia Suvari, Chief Legal Officer, earned $5.9M in 2020, a 91% increase compared to previous year.
Related executives
Ted Love
Global Blood Therapeutics
Chief Executive Officer
David Johnson
Global Blood Therapeutics
Chief Commercial Officer
Jeffrey Farrow
Global Blood Therapeutics
Chief Financial Officer
Jung Choi
Global Blood Therapeutics
Chief Business and Strategy Officer
Tricia Suvari
Global Blood Therapeutics
Chief Legal Officer
You may also like
Source: SEC filing on April 28, 2021.